Amping up HIV antibodies

被引：4

作者：

Burton, Dennis R. ^{[1
,2
]}

机构：

[1] Scripps Res Inst, Dept Immunol & Microbiol, Int AIDS Vaccine Initiat IAVI Neutralizing Antibo, Consortium HIV AIDS Vaccine Dev, La Jolla, CA 92037 USA

[2] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA

来源：

SCIENCE | 2021年 / 372卷 / 6549期

关键词：

PASSIVE-IMMUNIZATION; PROTECTION; CHALLENGE; TITER;

D O I：

10.1126/science.abf5376

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：1397 / 1398

页数：2

共 15 条

[1] T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers [J].

Arunachalam, Prabhu S. ;

Charles, Tysheena P. ;

Joag, Vineet ;

Bollimpelli, Venkata S. ;

Scott, Madeleine K. D. ;

Wimmers, Florian ;

Burton, Samantha L. ;

Labranche, Celia C. ;

Petitdemange, Caroline ;

Gangadhara, Sailaja ;

Styles, Tiffany M. ;

Quarnstrom, Clare F. ;

Walter, Korey A. ;

Ketas, Thomas J. ;

Legere, Traci ;

Reddy, Pradeep Babu Jagadeesh ;

Kasturi, Sudhir Pai ;

Tsai, Anthony ;

Yeung, Bertrand Z. ;

Gupta, Shakti ;

Tomai, Mark ;

Vasilakos, John ;

Shaw, George M. ;

Kang, Chil-Yong ;

Moore, John P. ;

Subramaniam, Shankar ;

Khatri, Purvesh ;

Montefiori, David ;

Kozlowski, Pamela A. ;

Derdeyn, Cynthia A. ;

Hunter, Eric ;

Masopust, David ;

Amara, Rama R. ;

Pulendran, Bali .

NATURE MEDICINE, 2020, 26 (06) :932-+

[2] Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition [J].

Corey, L. ;

Gilbert, P. B. ;

Juraska, M. ;

Montefiori, D. C. ;

Morris, L. ;

Karuna, S. T. ;

Edupuganti, S. ;

Mgodi, N. M. ;

deCamp, A. C. ;

Rudnicki, E. ;

Huang, Y. ;

Gonzales, P. ;

Cabello, R. ;

Orrell, C. ;

Lama, J. R. ;

Laher, F. ;

Lazarus, E. M. ;

Sanchez, J. ;

Frank, I. ;

Hinojosa, J. ;

Sobieszczyk, M. E. ;

Marshall, K. E. ;

Mukwekwerere, P. G. ;

Makhema, J. ;

Baden, L. R. ;

Mullins, J. I. ;

Williamson, C. ;

Hural, J. ;

McElrath, M. J. ;

Bentley, C. ;

Takuva, S. ;

Lorenzo, M. M. Gomez ;

Burns, D. N. ;

Espy, N. ;

Randhawa, A. K. ;

Kochar, N. ;

Piwowar-Manning, E. ;

Donnell, D. J. ;

Sista, N. ;

Andrew, P. ;

Kublin, J. G. ;

Gray, G. ;

Ledgerwood, J. E. ;

Mascola, J. R. ;

Cohen, M. S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11) :1003-1014

[3] PREVENTION OF HIV-1 INFECTION IN CHIMPANZEES BY GP120 V3 DOMAIN-SPECIFIC MONOCLONAL-ANTIBODY [J].

EMINI, EA ;

SCHLEIF, WA ;

NUNBERG, JH ;

CONLEY, AJ ;

EDA, Y ;

TOKIYOSHI, S ;

PUTNEY, SD ;

MATSUSHITA, S ;

COBB, KE ;

JETT, CM ;

EICHBERG, JW ;

MURTHY, KK .

NATURE, 1992, 355 (6362) :728-730

[4] Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1 [J].

Gauduin, MC ;

Parren, PWHI ;

Weir, R ;

Barbas, CF ;

Burton, DR ;

Koup, RA .

NATURE MEDICINE, 1997, 3 (12) :1389-1393

[5] Long-Acting HIV Drugs for Treatment and Prevention [J].

Gulick, Roy M. ;

Flexner, Charles .

ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 :137-150

[6] Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primates [J].

Hangartner, Lars ;

Beauparlant, David ;

Rakasz, Eva ;

Nedellec, Rebecca ;

Hoze, Nathanael ;

McKenney, Katherine ;

Martins, Mauricio A. ;

Seabright, Gemma E. ;

Allen, Joel D. ;

Weiler, Andrea M. ;

Friedrich, Thomas C. ;

Regoes, Roland R. ;

Crispin, Max ;

Burton, Dennis R. .

SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (585)

[7]

IAVI/Wellcome, 2020, EXP ACC MON ANT BAS

[8] Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus [J].

Johnson, S ;

Oliver, C ;

Prince, GA ;

Hemming, VG ;

Pfarr, DS ;

Wang, SC ;

Dormitzer, M ;

OGrady, J ;

Koenig, S ;

Tamura, JK ;

Woods, R ;

Bansal, G ;

Couchenour, D ;

Tsao, E ;

Hall, WC ;

Young, JF .

JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (05) :1215-1224

[9] Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies [J].

Li, M ;

Gao, F ;

Mascola, JR ;

Stamatatos, L ;

Polonis, VR ;

Koutsoukos, M ;

Voss, G ;

Goepfert, P ;

Gilbert, P ;

Greene, KM ;

Bilska, M ;

Kothe, DL ;

Salazar-Gonzalez, JF ;

Wei, XP ;

Decker, JM ;

Hahn, BH ;

Montefiori, DC .

JOURNAL OF VIROLOGY, 2005, 79 (16) :10108-10125

[10] Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies [J].

McCoy, Laura E. ;

Falkowska, Emilia ;

Doores, Katie J. ;

Le, Khoa ;

Sok, Devin ;

van Gils, Marit J. ;

Euler, Zelda ;

Burger, Judith A. ;

Seaman, Michael S. ;

Sanders, Rogier W. ;

Schuitemaker, Hanneke ;

Poignard, Pascal ;

Wrin, Terri ;

Burton, Dennis R. .

PLOS PATHOGENS, 2015, 11 (08)

← 1 2 →